In an adult patient with elevated red blood cell count, hemoglobin, and hematocrit but normal white blood cell and platelet counts, what is the likely diagnosis and how should I evaluate and manage possible polycythemia?

Evaluation and Management of Mild Erythrocytosis

This patient's CBC shows only mild elevation in RBC, hemoglobin, and hematocrit (HCT 46.8%) with completely normal WBC and platelet counts, which does not meet diagnostic thresholds for polycythemia vera and most likely represents normal physiologic variation or relative polycythemia from dehydration. 1

Why This is NOT Polycythemia Vera

The hematocrit of 46.8% falls below the WHO 2016 diagnostic threshold for polycythemia vera (PV), which requires HCT >49% in men or >48% in women. 2, 1 Additionally:

• Normal platelet count (308 × 10³/µL): PV typically presents with thrombocytosis ≥450 × 10⁹/L in 53% of cases 2, 1, 3
• Normal WBC count (7.4 × 10³/µL): PV commonly shows leukocytosis ≥11 × 10⁹/L in 49% of patients 2, 1, 3
• Absence of PV-specific features: No splenomegaly, aquagenic pruritus, or erythromelalgia documented 1, 4

Most Likely Explanations

Relative (Apparent) Polycythemia

Mild dehydration causing plasma volume contraction is the most common cause of borderline hematocrit elevation without true increase in red cell mass. 1 This should be evaluated by:

• Ensuring adequate hydration status before repeat testing 1
• Recognizing that about 5% of healthy individuals will have values just outside the reference range due to normal statistical variation 1

Smoking-Related Polycythemia

Chronic smoking stimulates erythropoietin production through carbon monoxide exposure, leading to genuine but secondary polycythemia. 1 Key points:

• Obtain detailed smoking history 1
• This typically resolves after smoking cessation 1

Recommended Diagnostic Approach

For this patient with HCT 46.8% and otherwise normal CBC, extensive polycythemia workup is NOT warranted. 1 Instead:

1. Repeat CBC in 3 months to confirm persistence 1
2. Assess hydration status and ensure adequate fluid intake before repeat testing 1
3. Document smoking history if applicable 1
4. Compare with prior baseline values if available; a sustained increase of ≥2 g/dL hemoglobin from baseline would warrant further investigation 1

When to Pursue Further Workup

Only proceed with polycythemia evaluation if repeat testing shows:

• Hemoglobin >16.5 g/dL (men) or >16.0 g/dL (women) 2, 1, 3
• Hematocrit >49% (men) or >48% (women) 2, 1
• Development of thrombocytosis (≥450 × 10⁹/L) or leukocytosis (≥11 × 10⁹/L) 2, 1
• New clinical features: splenomegaly, aquagenic pruritus, erythromelalgia, or unexplained thrombosis 1, 3, 4

If Further Workup Becomes Necessary

Should values meet diagnostic thresholds on repeat testing, the evaluation sequence is:

1. Measure serum erythropoietin (EPO) 1

   • Low EPO (>90% specific for PV) → proceed to JAK2 testing 1
   • Normal EPO → still test JAK2 (sensitivity of low EPO only ~70%) 1
   • Elevated EPO → investigate secondary causes 1

2. Order JAK2 V617F mutation testing 2, 1, 3

   • Present in >95% of PV patients 2, 1, 3
   • If negative, test for JAK2 exon 12 mutations 2, 1

3. Bone marrow biopsy if JAK2 positive with low/normal EPO 2, 1

   • Look for hypercellularity with trilineage growth (panmyelosis) 2, 1
   • Megakaryocyte clusters with giant, pleomorphic forms 1
   • Decreased marrow iron stores 1

Critical Pitfall to Avoid

Do not initiate phlebotomy or cytoreductive therapy based on this isolated mild elevation. 5 Therapeutic phlebotomy is indicated only when:

• Hemoglobin >20 g/dL AND hematocrit >65% with hyperviscosity symptoms 5
• Confirmed PV diagnosis with goal HCT <45% 3

Aggressive phlebotomy without confirmed diagnosis risks iron depletion, decreased oxygen-carrying capacity, and increased stroke risk. 5